Evidence map›Paper›PMID 24236031›Full record

ArticlePloS one2013

2A and the auxin-based degron system facilitate control of protein levels in Plasmodium falciparum.

Andrea Kreidenweiss, Annika V Hopkins, Benjamin Mordmüller

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Article
  3. Specific auxin and medium combinations alterbioRxiv : the preprint server for biology · 2025
    Article
  4. Review
  5. Specific auxin and medium combinations altermicroPublication biology · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Rapid, efficient auxin-inducible protein degradation inbioRxiv : the preprint server for biology · 2023
    Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Andrea KreidenweissInstitute of Tropical Medicine, University of Tübingen, Tübingen, Germany.
Annika V Hopkins
Benjamin Mordmüller
University of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Analysis of gene function in Plasmodium falciparum, the most important human malaria parasite, is restricted by the lack of robust and simple reverse genetic tools. Approaches to manipulate protein levels post-translationally are powerful tools to study protein-off effects especially in the haploid malaria parasite where genetic knockouts of essential genes are lethal. We investigated if the auxin-inducible degron system is functional in P. falciparum and found that degron-tagged yellow fluorescent protein levels were efficiently reduced upon addition of auxin which otherwise had no effect on parasite viability. The genetic components required in this conditional approach were co-expressed in P. falciparum by applying the small peptide 2A. 2A is a self-processing peptide from Foot-And-Mouth Disease virus that allows the whole conditional system to be accommodated on a single plasmid vector and ensures stoichiometric expression levels.

Indexed as

Bacterial ProteinsCysteine EndopeptidasesHeLa CellsHumansIndoleacetic AcidsInhibitory Concentration 50Luminescent ProteinsPlasmodium falciparumProteolysisProtozoan ProteinsTranscriptional ActivationViral ProteinsBacterial ProteinsCysteine EndopeptidasesIndoleacetic AcidsLuminescent ProteinsProtozoan ProteinsViral Proteinsyellow fluorescent protein, Bacteria

Identifiers

PMID24236031
PMCPMC3827281
OpenAlexW1989582185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.